Use of efletirizine for treating persistent allergic rhinitis

A method of treating a subject having persistent allergic rhinitis, the method comprising administering to the subject an effective amount of a composition comprising efletirizine, a crystalline form thereof, or a pharmaceutically acceptable salt thereof.

A method of decreasing the symptoms of persistent allergic rhinitis in a subject, the method comprising administering to the subject an effective amount of a composition comprising efletirizine, a crystalline form thereof or a pharmaceutically acceptable salt thereof.

A method of treating a subject having rhinorrhea, the method comprising administering to the subject an effective amount of a composition comprising efletirizine, a crystalline form thereof or a pharmaceutically acceptable salt thereof.

A method of treating a subject having nasal obstructions, the method comprising administering to the subject an effective amount of a compositing comprising efletirizine, a crystalline form thereof or a pharmaceutically acceptable salt thereof.

A method of treating nasal itching in a subject, the method comprising administering to the subject an effective amount of a composition comprising efletirizine, a crystalline form thereof or a pharmaceutically acceptable salt thereof.

A method of treating sneezing in a subject, the method comprising administering to the subject an effective amount of a composition comprising efletirizine, a crystalline form thereof or a pharmaceutically acceptable salt thereof.

A method of treating a subject having ocular pruritis, the method comprising administering to the subject an effective amount of a composition comprising efletirizine, a crystalline form thereof or a pharmaceutically acceptable salt thereof.